Modern treatment approaches for patients with IV stage of non-small cell lung cancer
Introduction. Lung cancer is currently the most common malignancy (1.6 million new cases annually), after non-melanoma skin cancer and the leading cause of cancer-related deaths (1.4 million annually). In Ukraine IV stage of the disease is diagnosed approximately in 27% of patients before their t...
Saved in:
| Main Author: | А. V. Kadzhoian |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaporizhzhia State Medical and Pharmaceutical University
2013-06-01
|
| Series: | Zaporožskij Medicinskij Žurnal |
| Subjects: | |
| Online Access: | http://zmj.zsmu.edu.ua/article/view/13646/11900 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CLINICAL SIGNIFICANCE OF THE DELAY IN STARTING SPECIAL TREATMENT FOR PATIENTS WITH SATGE III INOPERABLE NON-SMALL CELL LUNG CANCER: RESULTS OF STUDY AND LITERATURE REVIEW
by: Е. P. Solovyeva, et al.
Published: (2016-02-01) -
Regional Chemotherapy Infusion Via the Bronchial Artery in Combined Treatment of Non-Small Cell Lung Cancer
by: K. Sh. Gantsev, et al.
Published: (2020-11-01) -
Prognostic Value of the Number of Circulating Tumor Cells in Patients with Metastatic Non-Small Cell Lung Cancer
by: Arthur B. Volovetsky, et al.
Published: (2025-04-01) -
Comparative analysis of first-generation epidermal growth factor receptor inhibitors combined with chemotherapy versus third-generation epidermal growth factor receptor inhibitors in the treatment of advanced non-small cell lung cancer: a systematic review and meta-analysis
by: Siyan Peng, et al.
Published: (2025-08-01) -
Thermal ablation included in multimodality treatment predicts enhanced survival in advanced non-small cell lung cancer: a propensity score-matched outcome study
by: Stella Chin-Shaw Tsai, et al.
Published: (2025-12-01)